PT  - JOURNAL ARTICLE
AU  - PERRINE CAPMAS
AU  - VALÉRIE BILLARD
AU  - SEBASTIEN GOUY
AU  - CATHERINE LHOMMÉ
AU  - PATRICIA PAUTIER
AU  - PHILIPPE MORICE
AU  - CATHERINE UZAN
TI  - Impact of Epidural Analgesia on Survival in Patients Undergoing Complete Cytoreductive Surgery for Ovarian Cancer
DP  - 2012 Apr 01
TA  - Anticancer Research
PG  - 1537--1542
VI  - 32
IP  - 4
4099  - http://ar.iiarjournals.org/content/32/4/1537.short
4100  - http://ar.iiarjournals.org/content/32/4/1537.full
SO  - Anticancer Res2012 Apr 01; 32
AB  - Background: Potential benefits of regional analgesia in reduction of cancer recurrence have been reported for breast and prostate cancer. The aim of this study was to evaluate the influence of regional analgesia on recurrence-free survival and overall survival in patients with advanced-stage ovarian cancer (ASOC) following complete cytoreduction. Patients and Methods: This is a retrospective study of 104 patients who had undergone complete cytoreduction for ASOC between 01/2007 and 12/2009: 51 with patient controlled epidural analgesia (PCEA) and 53 without PCEA. Results: No significant difference was found between the two groups in terms of overall survival, while there was a trend in favour of PCEA for disease free survival. Conclusion: In our study, regional analgesia had no clear impact on cancer recurrence. More studies on this subject are warranted in order to determine the possible impact of regional analgesia on ASOC.